Physician
Urgent Care at Children's, INC.
Urgent Care at Children's, INC. was paid $48.86M by Medicaid between Jan 2018 and Dec 2024, across 88 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 29% of everything it billed.
33Billing provider infoURGENT CARE AT CHILDREN'S, INC.
BROOKHAVEN, GA 30329
BROOKHAVEN, GA 30329
33aNPI1659425825assigned 01/23/2007
33bProvider typePediatrics Physician
28Total paid$48.86M
24GClaims636,358
24DCodes billed88
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Georgia
Rank by total paid#1 of 220
Median peer was paid$57K
This provider vs. median852×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 103,154 | $7.13M | |
| 2019 | 110,506 | $7.64M | |
| 2020 | 60,684 | $4.29M | |
| 2021 | 87,720 | $7.09M | |
| 2022 | 117,756 | $9.72M | |
| 2023 | 99,885 | $8.04M | |
| 2024incomplete | 56,653 | $4.96M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 29% | 144,005 | 141,291 | $14.03M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 22% | 159,674 | 156,701 | $10.89M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 21% | 102,381 | 100,574 | $10.13M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 12% | 37,341 | 36,868 | $5.79M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.9% | 21,434 | 21,026 | $3.36M |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.8% | 85,626 | 84,575 | $2.32M |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 1.3% | 4,016 | 3,973 | $619K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 5,835 | 5,743 | $376K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | <1% | 4,410 | 4,375 | $241K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,430 | 8,316 | $160K |
| 90378 | <1% | 40 | 40 | $131K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,778 | 4,697 | $118K |
76 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 2,819 | $117K |
| 99284 | Emergency room visit (serious) | <1% | 1,261 | $84K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 707 | $73K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 632 | $65K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 663 | $45K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 803 | $45K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 333 | $36K |
| 81001 | <1% | 6,594 | $29K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,512 | $27K |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 5,534 | $25K |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 3,997 | $19K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 445 | $17K |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 9,365 | $13K |
| 99000 | <1% | 5,139 | $10K | |
| 99460 | <1% | 104 | $9K | |
| 51701 | <1% | 162 | $9K | |
| 99285 | Emergency room visit (most serious) | <1% | 63 | $8K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 79 | $8K |
| 86140 | <1% | 779 | $5K | |
| J3490 | Unclassified drugs | <1% | 1,980 | $5K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 28 | $4K |
| 92567 | <1% | 200 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,499 | $4K |
| 74019 | <1% | 174 | $4K | |
| 94664 | <1% | 139 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 160 | $2K |
| 99051 | <1% | 104 | $2K | |
| 96127 | <1% | 376 | $2K | |
| 73610 | <1% | 93 | $2K | |
| 74018 | <1% | 96 | $2K | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 2,871 | $1K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 19 | $1K |
| 72081 | <1% | 44 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 52 | $931.85 |
| 96160 | <1% | 197 | $801.75 | |
| 90686 | <1% | 797 | $761.35 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 64 | $744.14 |
| D1206 | Topical application of fluoride varnish | <1% | 38 | $730.21 |
| 70360 | <1% | 43 | $679.66 | |
| 92551 | <1% | 134 | $584.07 | |
| 73630 | <1% | 25 | $494.60 | |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 340 | $493.54 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 16 | $478.71 |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 15 | $449.40 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 201 | $393.30 |
| 99173 | <1% | 155 | $360.78 | |
| 94010 | <1% | 15 | $359.82 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 28 | $330.67 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 239 | $297.00 |
| 81003 | <1% | 85 | $243.13 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 442 | $224.58 |
| 85018 | <1% | 72 | $215.12 | |
| 73140 | <1% | 14 | $214.50 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17 | $214.25 |
| 85652 | <1% | 56 | $211.76 | |
| 81002 | <1% | 51 | $174.65 | |
| 96161 | <1% | 39 | $156.55 | |
| 97802 | <1% | 1,242 | $104.23 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $38.93 |
| 36416 | <1% | 75 | $8.40 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 40 | $6.94 |
| S9451 | Exercise classes, non-physician provider, per session | 0% | 1,125 | $0.00 |
| 90688 | 0% | 62 | $0.00 | |
| 90651 | 0% | 66 | $0.00 | |
| 90620 | 0% | 15 | $0.00 | |
| 99070 | 0% | 12 | $0.00 | |
| 92558 | 0% | 14 | $0.00 | |
| 94760 | 0% | 16 | $0.00 | |
| 90723 | 0% | 13 | $0.00 | |
| 90670 | 0% | 45 | $0.00 | |
| 99072 | 0% | 564 | $0.00 | |
| 98960 | 0% | 13 | $0.00 | |
| 90672 | 0% | 94 | $0.00 | |
| 90700 | 0% | 12 | $0.00 | |
| 90734 | 0% | 43 | $0.00 | |
| 5250F | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFOWLER, RUTH (CHIEF FINANCIAL OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Scottish Rite Children's Medical Center | Atlanta, GA | $493.38M |
| Marcus Autism Center, INC. | Brookhaven, GA | $3.39M |
| Children's Sedation Services, LLC | Brookhaven, GA | $1.09M |
| Children's Anesthesia Services, LLC | Brookhaven, GA | $928K |
| Children's BMH Providers, LLC | Brookhaven, GA | $193K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.